America pays too much for medicine. Here’s who is doing something about it
Americans face significantly higher prescription drug prices compared to other countries, prompting President Trump to push for reforms. The TrumpRx initiative and Most Favored Nation pricing agreements have created pressure on drug manufacturers to lower prices. However, temporary measures may not address the long-term pricing issues, making state-level actions like Louisiana's proposed Prescription Drug Affordability Board crucial for transparency and understanding drug cost impacts.
- ▪President Trump has highlighted the disparity in drug prices between the U.S. and other nations.
- ▪Louisiana's legislature is considering a bill to create a Prescription Drug Affordability Board to gather information on high-cost drugs.
- ▪Recent reports indicate that prescription drug prices have increased by about 4%, outpacing inflation.
Opening excerpt (first ~120 words) tap to expand
President Donald Trump has said it plainly: Americans pay “massively higher prices than other nations pay for the same exact pill, from the same factory.” He’s right, and unlike many politicians before him, he forced the pharmaceutical industry to the table. TrumpRx and his Most Favored Nation pricing agreements achieved something Washington insiders long insisted was impossible: They created real pressure on drugmakers to lower prices for American patients. Recommended Stories The real admissions scandal: Elite universities don’t trust black excellence Quality education needs an act of Congress Alaska energy is American energy, which depends on a strong Alaskan economy That deserves credit.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
